Summary: From the “brain fog” reported after COVID-19 to the cognitive decline linked to HIV and hepatitis, viral infections can leave a lasting impact on memory, attention, and mental processing. A large cross-disciplinary meta-analysis examined more than 900 scientific papers to map the immune signatures that predict recovery or deterioration of cognitive function after infection.
The researchers found that the immune response to viruses does more than fight infection in the lungs or bloodstream: it shapes a chemical environment in the brain that can either protect cognition or contribute to decline. These findings point to immune markers that could guide diagnosis, prognosis, and treatment of post-infectious cognitive symptoms.
Key Facts
- “Harmful” immune signature: Elevated activated monocytes (a type of white blood cell) and pro-inflammatory cytokines correlate with worse episodic memory and slower information processing.
- “Protective” immune signature: Higher levels of activated CD4+ T cells and anti-inflammatory cytokines are associated with preserved cognitive abilities.
- Balance matters: Cognitive outcomes depend on the balance between inflammatory and anti-inflammatory signals, not simply on which virus caused the infection.
- Cross-viral similarity: SARS-CoV-2, HIV, herpesviruses, and hepatitis display similar immune–cognition patterns, suggesting common biological pathways across different infections.
- Therapeutic roadmap: Identifying and modulating these immune signatures offers a biological framework for treating long COVID and other post-infectious cognitive syndromes.
Source: University of Geneva
How do viral infections affect memory, attention, and concentration? Interest in this question surged during the COVID-19 pandemic and has since expanded to other viral infections such as HIV, herpes, and hepatitis. Persistent cognitive symptoms after infection have prompted researchers to look beyond isolated disease studies and search for common immune mechanisms.
A multidisciplinary team from the University of Geneva and Geneva University Hospital systematically reviewed over 900 articles that examined links between immune markers and cognitive performance across multiple viral infections. Their synthesis, published in Neuroscience & Biobehavioral Reviews, highlights consistent immune–cognitive relationships and identifies biomarkers associated with cognitive decline or preservation.
Despite decades of investigation, the specific cognitive effects of viral exposure have remained fragmented across disease-focused studies. Many prior reports relied on global cognitive screening tools applied within a single infectious context, limiting cross-disease comparisons. This new transnosological review compiles and reanalyzes evidence to reveal shared immune pathways that influence cognition.
The review narrowed 931 studies to 32 that met strict inclusion criteria, collectively representing 25,325 participants across SARS-CoV-2, HIV, herpes, hepatitis, Epstein–Barr virus, and co-infections. Across these studies, several reproducible patterns emerged:
- Higher levels of circulating CD14+CD16+ intermediate monocytes were repeatedly linked with slower processing speed, poorer episodic memory, and reduced mental flexibility.
- Greater CD4+ T cell counts tended to predict better processing speed, whereas reductions in T and B lymphocytes combined with elevated IgG often preceded memory and attention problems.
- Pro-inflammatory cytokines such as IL-6, TNF-α, and IFN-γ were frequently associated with overlapping cognitive impairments, while anti-inflammatory signals like IL-10 correlated with stronger executive and memory performance.
Interpretation and implications
The evidence suggests that a persistent, dysregulated immune response—not the presence of a specific virus alone—contributes to long-term cognitive symptoms. In practical terms, this means that monitoring immune markers could help identify individuals at risk for prolonged cognitive difficulties and guide interventions aimed at restoring immune balance.
These conclusions reinforce findings from ongoing clinical projects focused on post-COVID cognitive outcomes and are supported by funded research initiatives seeking to map neuropsychological and neuropsychiatric deficits after infection. By revealing convergent immune signatures across viral illnesses, the review provides a foundation for future biomarker-driven treatments and clinical trials.
Key Questions Answered:
A: When the immune system responds to a virus it releases pro-inflammatory cytokines. If these inflammatory signals persist, they can influence the brain—either by crossing the blood–brain barrier or by activating brain-resident immune cells—disrupting neuronal connections required for memory and focus.
A: The review indicates that long-term cognitive difficulties are tied to persistent immune activation. Many people recover as inflammation resolves, but those with prolonged elevations in activated monocytes and pro-inflammatory cytokines are at higher risk for lasting problems. Future research aims to identify strategies to normalize these immune responses.
A: No. Similar immune patterns and cognitive consequences have been observed in HIV, hepatitis, and herpes infections. The COVID-19 pandemic highlighted these associations but did not create them; rather, it accelerated cross-disease attention to immune–cognition links.
Editorial Notes:
- This article was edited by an editor at Neuroscience News.
- The journal paper was reviewed in full for accuracy.
- Additional context and clarification were added by staff to aid reader understanding.
About this neurology research news
Author: Antoine Guenot
Source: University of Geneva
Contact: Antoine Guenot – University of Geneva
Image: Image credited to Neuroscience News
Original Research: Open access. “Immune-cognitive relationships across viral infections: A transnosological systematic review” by Anthony Nuber-Champier, Gautier Bréville, Patrice H. Lalive, Frédéric Assal, and Julie A. Péron. DOI: 10.1016/j.neubiorev.2026.106588
Abstract
Immune-cognitive relationships across viral infections: A transnosological systematic review
The emergence of SARS-CoV-2 renewed interest in how immunity and cognition interact. Although many studies have investigated cognitive outcomes in specific infections—primarily HIV, herpes, and hepatitis—their use of broad screening tools limited cross-study comparisons. This narrative systematic review adopts a transnosological approach to summarize immune–cognition relationships across viral infections. Out of 931 studies, 32 met inclusion criteria, totaling 25,325 participants. Consistent findings included associations between elevated CD14+CD16+ intermediate monocytes and slower processing speed, reduced episodic memory, and lower mental flexibility. Higher CD4+ T cell counts correlated with improved processing speed, while reduced lymphocyte levels combined with elevated IgG predicted deficits in memory and attention. Pro-inflammatory cytokines (e.g., IL-6, TNF-α, IFN-γ) were linked to overlapping cognitive impairments, whereas anti-inflammatory cytokines such as IL-10 were associated with preserved executive and memory functions.